# Hepatocellular Carcinoma Using Stereotactic Body Radiotherapy

> **NCT01850316** · NA · UNKNOWN · sponsor: **British Columbia Cancer Agency** · enrollment: 13 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **RADIATION:** Stereotactic Ablative Radiotherapy

## Key facts

- **NCT ID:** NCT01850316
- **Lead sponsor:** British Columbia Cancer Agency
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-07
- **Primary completion:** 2018-08
- **Final completion:** 2020-08
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2018-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01850316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01850316, "Hepatocellular Carcinoma Using Stereotactic Body Radiotherapy". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT01850316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*